These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

458 related items for PubMed ID: 7510617

  • 1. Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders.
    Wiseman LR, Faulds D.
    Drugs; 1994 Jan; 47(1):116-52. PubMed ID: 7510617
    [Abstract] [Full Text] [Related]

  • 2. Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders.
    McCallum RW, Prakash C, Campoli-Richards DM, Goa KL.
    Drugs; 1988 Dec; 36(6):652-81. PubMed ID: 3065057
    [Abstract] [Full Text] [Related]

  • 3. A risk-benefit assessment of cisapride in the treatment of gastrointestinal disorders.
    Tack J, Coremans G, Janssens J.
    Drug Saf; 1995 Jun; 12(6):384-92. PubMed ID: 8527013
    [Abstract] [Full Text] [Related]

  • 4. Cisapride: a gastrointestinal prokinetic drug.
    Barone JA, Jessen LM, Colaizzi JL, Bierman RH.
    Ann Pharmacother; 1994 Apr; 28(4):488-500. PubMed ID: 8038476
    [Abstract] [Full Text] [Related]

  • 5. Use of metoclopramide, domperidone, and cisapride in the management of diabetic gastroparesis.
    Brown CK, Khanderia U.
    Clin Pharm; 1990 May; 9(5):357-65. PubMed ID: 2190745
    [Abstract] [Full Text] [Related]

  • 6. [Pharmacologic and clinical differentiation of prokinetic drugs].
    May B, Greving I.
    Leber Magen Darm; 1996 Jul; 26(4):193-8. PubMed ID: 8965601
    [Abstract] [Full Text] [Related]

  • 7. Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study.
    Inauen W, Emde C, Weber B, Armstrong D, Bettschen HU, Huber T, Scheurer U, Blum AL, Halter F, Merki HS.
    Gut; 1993 Aug; 34(8):1025-31. PubMed ID: 8174947
    [Abstract] [Full Text] [Related]

  • 8. Domperidone: a peripherally acting dopamine2-receptor antagonist.
    Barone JA.
    Ann Pharmacother; 1999 Apr; 33(4):429-40. PubMed ID: 10332535
    [Abstract] [Full Text] [Related]

  • 9. Cisapride, metoclopramide, and ranitidine in the treatment of severe nonulcer dyspepsia.
    Archimandritis A, Tzivras M, Fertakis A, Emmanuel A, Laoudi F, Kalantzis N, Anthopoulou H, Michailidis D.
    Clin Ther; 1992 Apr; 14(4):553-61. PubMed ID: 1525789
    [Abstract] [Full Text] [Related]

  • 10. Cisapride compared with ranitidine in the treatment of functional dyspepsia.
    Carvalhinhos A, Fidalgo P, Freire A, Matos L.
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):411-7. PubMed ID: 7614103
    [Abstract] [Full Text] [Related]

  • 11. Lansoprazole: an update of its place in the management of acid-related disorders.
    Matheson AJ, Jarvis B.
    Drugs; 2001 May; 61(12):1801-33. PubMed ID: 11693467
    [Abstract] [Full Text] [Related]

  • 12. Prokinetic agents for lower gastrointestinal motility disorders.
    Longo WE, Vernava AM.
    Dis Colon Rectum; 1993 Jul; 36(7):696-708. PubMed ID: 8348856
    [Abstract] [Full Text] [Related]

  • 13. Effect of prokinetic agents, cisapride and metoclopramide, on the bioavailability in humans and intestinal permeability in rats of ranitidine, and intestinal charcoal transit in rats.
    Lee HT, Lee YJ, Chung SJ, Shim CK.
    Res Commun Mol Pathol Pharmacol; 2000 Jul; 108(5-6):311-23. PubMed ID: 11958284
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of cisapride in functional dyspepsia resistant to domperidone or metoclopramide: a double-blind, placebo-controlled study.
    Van Outryve M, De Nutte N, Van Eeghem P, Gooris JP.
    Scand J Gastroenterol Suppl; 1993 Jul; 195():47-52; discussion 52-3. PubMed ID: 8516658
    [Abstract] [Full Text] [Related]

  • 15. Aggravation of parkinsonian tremor by cisapride.
    Sempere AP, Duarte J, Cabezas C, Clavería LE, Coria F.
    Clin Neuropharmacol; 1995 Feb; 18(1):76-8. PubMed ID: 8665538
    [Abstract] [Full Text] [Related]

  • 16. [Prokinetic activity and antral inflammation. Usefulness of cisapride combined with H2 antagonists in gastritis].
    Dallera F, Scanzi G, Gendarini A.
    Clin Ter; 1994 Jan; 144(1):23-6. PubMed ID: 8168347
    [Abstract] [Full Text] [Related]

  • 17. Determinants of response to a prokinetic agent in neuropathic chronic intestinal motility disorder.
    Camilleri M, Balm RK, Zinsmeister AR.
    Gastroenterology; 1994 Apr; 106(4):916-23. PubMed ID: 8143996
    [Abstract] [Full Text] [Related]

  • 18. The current status of gastric prokinetic drugs.
    Schapira M, Henrion J, Heller FR.
    Acta Gastroenterol Belg; 1990 Apr; 53(4):446-57. PubMed ID: 1982914
    [Abstract] [Full Text] [Related]

  • 19. The effects of cisapride on antroduodenal co-ordination and gastric emptying.
    Johnson AG.
    Scand J Gastroenterol Suppl; 1989 Apr; 165():36-43. PubMed ID: 2690323
    [Abstract] [Full Text] [Related]

  • 20. Modulation of gastrointestinal motility beyond metoclopramide and domperidone : Pharmacological and clinical evidence for phytotherapy in functional gastrointestinal disorders.
    Madisch A, Vinson BR, Abdel-Aziz H, Kelber O, Nieber K, Kraft K, Storr M.
    Wien Med Wochenschr; 2017 May; 167(7-8):160-168. PubMed ID: 28424994
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.